EphB2 may be a therapeutical target to promote of the migration and invasion of cSCC cells and tumor angiogenesis, and in vitro and in vivo experiment both showed that EphB2 inhibition obvious suppressed the cell tumorigenesis, while inhibited cell apoptosis and altered the cell cycle 30. Here, EPHB2 is linked to neoplasm.